Search

everythinglearnresearchcommunity

for

Search:↓

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Baricitinib may effectively treat oral lichen planus.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Mogamulizumab can cause hair loss and skin rashes.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

JAK inhibitors may help improve symptoms in adults with APECED.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

The treatment was effective for advanced non-Hodgkin's lymphomas.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

Canakinumab's effect on COVID-19 outcomes is unclear.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.